Old CIC Events

Metabolic determinants of stemness in Pancreatic Ductal Adenocarcinoma
Dra. Patricia Sancho — Instituto de Investigación Sanitaria Aragón/ Centro de Investigación Biomédica de Aragón (CIBA) de Zaragoza.

DEFENSA DE TESIS DOCTORAL: Análisis funcional de los genes Usp26 y Hsf2bp como responsables de infertilidad humana
Natalia Felipe Medina — Centro de Investigación del Cáncer (CIC-IBMCC)

Diagnostic use and prognostic impact of genetic variants in systemic mastocytosis
Javier Ignacio Muñoz González — Centro de Investigación del Cáncer (CIC-IBMCC)

Using cryo-electron microscopy to study molecular mechanisms in cancer
Óscar Llorca — Structural Biology Programme. CNIO, Spanish National Cancer Research Centre. Madrid.

CAR-T cells for the treatment of cancer: current challenges and opportunities
Sonia Guedan — Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) [Barcelona]

A missense in HSF2BP causing Primary Ovarian Insufficiency affects meiotic recombination by its novel interactor C19ORF57/BRME1
Natalia Felipe Medina — Centro de Investigación del Cáncer (CIC-IBMCC), lab. 9

Identification of Differentially Expressed Genes and Network Analysis in the search of potential molecular signatures associated with breast cancer
Marina Mendiburu-Eliçabe Garganta — Centro de Investigación del Cáncer (CIC-IBMCC), lab. 7

Tyrosine Phosphorylation of the Myosin Regulatory Light Chain Controls Non-muscle Myosin II Assembly and Function in Migrating Cells.
Miguel Vicente Manzanares — Centro de Investigación del Cáncer

Nuevo análisis de células en tiempo real. Apoptosis, Proliferación, Esferoides y muchas otras funciones
NS — Sartorius

Understanding the transcriptome to treat KRAS-driven tumors: how far can we get?
Silve Vicent Cambra — Center for Applied Medical Research (CIMA) [Pamplona]

Oesophageal mechanic switch dictates developmental transition towards homeostasis.
María Pilar Alcolea — University of Cambridge [Cambridge, UK]

Mechanisms and consequences of large nuclear deformation : from microchannels to mammary tumors.
Matthieu Piel — Institut Curie de París